China Genetic Testing Market is Set for Strong Growth, To Reach US$ 4.90 Billion by 2024
by IVO Smith Business AnalystGenetic tests identify the
changes occurring in the genes, proteins or chromosomes of an individual. They
help in determining the chances of a person passing on a genetic disorder to
the next generation as well as their vulnerability to a suspected genetic
disease. The genetic testing market in China has witnessed rapid development
since the establishment of the first genomics company in 1999. The demand for
genetic testing services in the country is being driven by factors like aging
population, expanding middle class and investments in the healthcare sector.
The industry has also attracted international investors owing to rising demand
for non-invasive prenatal testing and growing research in the fields of
reproductive and oncology health.
According to the latest
report by IMARC Group, titled “China Genetic Testing Market: Industry Trends,
Share, Size, Growth, Opportunity and Forecast 2019-2024”,
the market reached a value of US$ 1.82 Billion in 2018.
Market Trends:
In an effort to expand its domestic biotechnology
sector, the Chinese Government has taken steps in the favor of genetic science
development. It identified genomics as a strategic field for the country’s
social and economic development in its 14th Five-Year
Plan. The Government also plans to document the genetic makeup of people from
nine different minority groups, in an attempt to decode hereditary information
within their genes.
Apart from this, the market for direct-to-consumer
DNA testing has also experienced massive growth driven by rising priority of
personal health and wellness among consumers. This trend has further been
supported by technological advancements which have reduced the cost of DNA
sequencing services. However, there is a lack of specifically-designed
educational programs for training medical genetic professionals in China.
Despite this hindrance, the China genetic testing market value is expected to
reach US$ 4.90 Billion by 2024, at a projected CAGR of 16.6% during 2019-2024.
Browse full report with detailed TOC and list of
figures and tables: https://www.imarcgroup.com/china-genetic-testing-market
About Us
IMARC Group is a leading market research
company that offers management strategy and market research worldwide. We
partner with clients in all sectors and regions to identify their highest-value
opportunities, address their most critical challenges, and transform their
businesses.
IMARC’s information products include major market,
scientific, economic and technological developments for business leaders in
pharmaceutical, industrial, and high technology organizations. Market forecasts
and industry analysis for biotechnology, advanced materials, pharmaceuticals,
food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company’s expertise.
Contact US: IMARC Group
309 2nd St, Brooklyn, NY 11215, USA
Website: www.imarcgroup.com
Email: sales@imarcgroup.com
USA: +1-631-791-1145, UK: +44-702-409-7331
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group
Sponsor Ads
Created on May 24th 2019 05:42. Viewed 515 times.